RE: A Cost-Effectiveness Modeling Evaluation Comparing a Biosimilar Follitropin Alfa Preparation With Its Reference Product for Live Birth Outcome in Germany, Italy and Spain

Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2019.1576181
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Informa UK Limited


Related search